EUVIMEDEUVIMED entdecken
Crossref

Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions

Gabriel Maldonado, Cristian Espinoza, Anna Arias, Anaís Muñoz, Germán Cabrera, María Cecilia Johnson, Juan Pablo Espinoza, Ignacio Gutiérrez, Pamela González, Gareth Owen, Renán Orellana-Walden, Ricardo D Moreno

Cells & Development · 2026

DOI: 10.1016/j.cdev.2026.204096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells & Development, 2026. Verfasst von Gabriel Maldonado und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago de Chile, Región Metropolitana, Chile. Hauptthemen laut MEDLINE: Endometriosis, Progesterone, Neovascularization, Pathologic, Angiogenesis. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Agency for Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Endometriosis is sustained by ectopic endometrial implants that remain proliferative and vascularized, making endocrine modulation a cornerstone of therapy. Estetrol (E4) an endogenous estrogen produced during pregnancy, with selective tissue activity, may modulate progesterone (P4) outputs in ectopic tissue and potentially shift lesion biology toward growth restraint without reinforcing vascular support. OBJECTIVE: To test whether E4 modifies P4 effects on lesion proliferation, apoptosis-related signaling, and angiogenic/endothelial activation in vivo. METHODS: Hormonally intact female mice bearing allografted endometriotic lesions received vehicle, E4 (3 mg/day), P4 (4.25 mg/day), or E4 + P4 once daily for 14 days. Lesions and eutopic endometrium were assessed by immunohistochemistry (Ki-67, cleaved caspase-3, BAX, VEGF, PECAM-1/CD31, Cyclin D1) with epithelial/stromal quantification, and endothelial angiogenic behavior was evaluated using a tube-formation assay. RESULTS: Lesions exhibited higher proliferative activity than eutopic endometrium. P4 reduced lesion proliferation, and the E4 + P4 combination produced the strongest growth restraint. Apoptosis-related markers increased under endocrine treatments, with the combined regimen showing robust activation. Notably, P4 enhanced angiogenesis-related readouts (VEGF and PECAM/CD31), whereas E4 + P4 prevented these increases and reduced endothelial tube formation, consistent with attenuated endothelial activation under the combined regimen. CONCLUSIONS: The E4-P4 combination supports a "balanced" endocrine profile-robust growth restraint without concurrent endothelial activation-thereby decoupling proliferation restraint from angiogenic activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisProgesteroneNeovascularization, PathologicAngiogenesisAnimalsFemaleCell ProliferationMiceApoptosisEndometriumVascular Endothelial Growth Factor APlatelet Endothelial Cell Adhesion Molecule-1

Stichwörter der Autor:innen

AngiogenesisApoptosisEndometriosisEstetrol (E4)Progesterone (P4)

Substanzen

ProgesteroneVascular Endothelial Growth Factor APlatelet Endothelial Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago de Chile, Región Metropolitana, Chile.
  • Instituto de Investigaciones Materno Infantil (IDIMI), Facultad de Medicina, Universidad de Chile, Santiago de Chile, Región Metropolitana, Chile.
  • Centro Integrativo de Biología y Química Aplicada, Facultad de Ciencias de la Salud, Universidad Bernardo O'Higgins, Santiago de Chile, Región Metropolitana, Chile.
  • Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago de Chile, Región Metropolitana, Chile; Instituto Milenio de Inmunología e Inmunoterapia, Santiago de Chile,…
  • Centro Integrativo de Biología y Química Aplicada, Facultad de Ciencias de la Salud, Universidad Bernardo O'Higgins, Santiago de Chile, Región Metropolitana, Chile. Electronic address: renan.orellana@ubo.cl.
  • Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago de Chile, Región Metropolitana, Chile. Electronic address: rmorenoa@uc.cl.

Förderung

  • National Agency for Research and Development

Zitieren

APA

Maldonado, G., Espinoza, C., Arias, A., Muñoz, A., Cabrera, G., Johnson, M. C., Espinoza, J. P., Gutiérrez, I., González, P., Owen, G., Orellana-Walden, R., & Moreno, R. D. (2026). Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions. Cells & Development. https://doi.org/10.1016/j.cdev.2026.204096

Vancouver

Maldonado G, Espinoza C, Arias A, Muñoz A, Cabrera G, Johnson MC, et al. Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions. Cells & Development. 2026. doi:10.1016/j.cdev.2026.204096

BibTeX
@article{Maldonado2026,
  author = {Maldonado, Gabriel and Espinoza, Cristian and Arias, Anna and Muñoz, Anaís and Cabrera, Germán and Johnson, María Cecilia and Espinoza, Juan Pablo and Gutiérrez, Ignacio and González, Pamela and Owen, Gareth and Orellana-Walden, Renán and Moreno, Ricardo D},
  title = {Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions},
  journal = {Cells & Development},
  year = {2026},
  doi = {10.1016/j.cdev.2026.204096}
}
Kostenlos starten →